EUVIMEDEUVIMED entdecken
Crossref

Cell-Autonomous Defense against Tuberculosis

Carl Nathan, John MacMicking

Cold Spring Harbor Perspectives in Medicine · 17.04.2026 · a041818

DOI: 10.1101/cshperspect.a041818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cold Spring Harbor Perspectives in Medicine, online erschienen am 17.04.2026. Verfasst von Carl Nathan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York 10065, USA cnathan@med.cornell.edu john.macmicking@yale.edu.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our ability to cope with Mycobacterium tuberculosis (Mtb) infection requires activated macrophages to help confer host defense. The extent to which these cells directly eliminate or restrain Mtb varies not only within different human populations but also within a given individual at different times following infection and in different lesions. Genetic studies of susceptible people reveal macrophage-activating cytokines like interferon (IFN)-γ and tumor necrosis factor (TNF) are key determinants of protective immunity against tuberculosis. Both cytokines mobilize macrophage effector programs to kill or restrict the bacterium. Among the downstream agents responsible for this inhibition are reactive nitrogen species (RNS) and reactive oxygen species (ROS); lysosomal and autophagic defense; and antimicrobial peptides, metabolites, and metal ion-binding proteins. Together these cell-autonomous effector pathways furnish toxic products or withhold essential micronutrients. It is a testament to the evolutionary fitness of Mtb that immune sterilization is often incomplete, although sufficient to ensure that most people infected with this airborne pathogen remain disease-free.

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York 10065, USA cnathan@med.cornell.edu john.macmicking@yale.edu.
  • Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut 06520, USA cnathan@med.cornell.edu john.macmicking@yale.edu.
  • Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
  • Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
  • Yale Systems Biology Institute, West Haven, Connecticut 06516, USA.

Zitieren

APA

Nathan, C., & MacMicking, J. (2026). Cell-Autonomous Defense against Tuberculosis. Cold Spring Harbor Perspectives in Medicine, a041818. https://doi.org/10.1101/cshperspect.a041818

Vancouver

Nathan C, MacMicking J. Cell-Autonomous Defense against Tuberculosis. Cold Spring Harbor Perspectives in Medicine. 2026:a041818. doi:10.1101/cshperspect.a041818

BibTeX
@article{Nathan2026,
  author = {Nathan, Carl and MacMicking, John},
  title = {Cell-Autonomous Defense against Tuberculosis},
  journal = {Cold Spring Harbor Perspectives in Medicine},
  year = {2026},
  pages = {a041818},
  doi = {10.1101/cshperspect.a041818}
}
Kostenlos starten →